If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

Their research has been published in Science Advances, titled "Coin-sized, fully integrated, and minimally invasive ...

Continuous glucose monitors are small devices that automatically track your blood sugar, aka your blood glucose level, ...

The Continuous Glucose Monitoring Market is Growing at a CAGR of 7.80%, Driven by the Increasing Prevalence of Prediabetes ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...